These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1333822)

  • 1. Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation.
    Del Bino G; Bruno S; Yi PN; Darzynkiewicz Z
    Cell Prolif; 1992 Nov; 25(6):537-48. PubMed ID: 1333822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells.
    Del Bino G; Skierski JS; Darzynkiewicz Z
    Exp Cell Res; 1991 Aug; 195(2):485-91. PubMed ID: 1649059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells.
    Del Bino G; Darzynkiewicz Z
    Cancer Res; 1991 Feb; 51(4):1165-9. PubMed ID: 1997159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle-related expression of p120 nucleolar antigen in normal human lymphocytes and in cells of HL-60 and MOLT-4 leukemic lines: effects of methotrexate, camptothecin, and teniposide.
    Gorczyca W; Bruno S; Melamed MR; Darzynkiewicz Z
    Cancer Res; 1992 Jun; 52(12):3491-4. PubMed ID: 1596908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of camptothecin on mitogenic stimulation of human lymphocytes: involvement of DNA topoisomerase I in cell transition from G0 to G1 phase of the cell cycle and in DNA replication.
    Bruno S; Giaretti W; Darzynkiewicz Z
    J Cell Physiol; 1992 Jun; 151(3):478-86. PubMed ID: 1338332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis of S-phase HL-60 cells induced by DNA topoisomerase inhibitors: detection of DNA strand breaks by flow cytometry using the in situ nick translation assay.
    Gorczyca W; Melamed MR; Darzynkiewicz Z
    Toxicol Lett; 1993 Apr; 67(1-3):249-58. PubMed ID: 8383887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cells.
    Del Bino G; Skierski JS; Darzynkiewicz Z
    Cancer Res; 1990 Sep; 50(18):5746-50. PubMed ID: 2168279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new action for topoisomerase inhibitors.
    Zucker RM; Elstein KH
    Chem Biol Interact; 1991; 79(1):31-40. PubMed ID: 1647887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.
    Bertrand R; Solary E; Jenkins J; Pommier Y
    Exp Cell Res; 1993 Aug; 207(2):388-97. PubMed ID: 7688316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different modes of cell-killing action between DNA topoisomerase I and II inhibitors revealed by kinetic analysis.
    Inaba M; Mitsuhashi J; Kawada S; Nakano H
    Jpn J Cancer Res; 1994 Feb; 85(2):187-93. PubMed ID: 8144400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis of rat thymocytes triggered by prednisolone, camptothecin, or teniposide is selective to G0 cells and is prevented by inhibitors of proteases.
    Bruno S; Lassota P; Giaretti W; Darzynkiewicz Z
    Oncol Res; 1992; 4(1):29-35. PubMed ID: 1374671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyploidy induction as a consequence of topoisomerase inhibition. A flow cytometric assessment.
    Zucker RM; Adams DJ; Bair KW; Elstein KH
    Biochem Pharmacol; 1991 Nov; 42(11):2199-208. PubMed ID: 1659821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytostatic and cytotoxic effects of fostriecin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemic cells.
    Hotz MA; Del Bino G; Lassota P; Traganos F; Darzynkiewicz Z
    Cancer Res; 1992 Mar; 52(6):1530-5. PubMed ID: 1540962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents.
    Gorczyca W; Gong J; Ardelt B; Traganos F; Darzynkiewicz Z
    Cancer Res; 1993 Jul; 53(13):3186-92. PubMed ID: 8319228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells.
    Traganos F; Ardelt B; Halko N; Bruno S; Darzynkiewicz Z
    Cancer Res; 1992 Nov; 52(22):6200-8. PubMed ID: 1330289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs.
    Del Bino G; Li X; Traganos F; Darzynkiewicz Z
    Leukemia; 1994 Feb; 8(2):281-8. PubMed ID: 7508535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in nuclear chromatin related to apoptosis or necrosis induced by the DNA topoisomerase II inhibitor fostriecin in MOLT-4 and HL-60 cells are revealed by altered DNA sensitivity to denaturation.
    Hotz MA; Traganos F; Darzynkiewicz Z
    Exp Cell Res; 1992 Jul; 201(1):184-91. PubMed ID: 1319346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different patterns of apoptosis of HL-60 cells induced by cycloheximide and camptothecin.
    Gong J; Li X; Darzynkiewicz Z
    J Cell Physiol; 1993 Nov; 157(2):263-70. PubMed ID: 8227159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The topoisomerase II inhibitor VM-26 induces marked changes in histone H1 kinase activity, histones H1 and H3 phosphorylation, and chromosome condensation in G2 phase and mitotic BHK cells.
    Roberge M; Th'ng J; Hamaguchi J; Bradbury EM
    J Cell Biol; 1990 Nov; 111(5 Pt 1):1753-62. PubMed ID: 2172257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines.
    Aldridge DR; Radford IR
    Cancer Res; 1998 Jul; 58(13):2817-24. PubMed ID: 9661896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.